Cancer Drug for Alzheimer's Treatment Concord NC

New research suggests that a cancer drug might be able to restore day-to-day memory in patients with Alzheimer's disease. The disease, the most common form of dementia among the elderly, is expected to afflict 120 million people worldwide by 2050. Often the first sign is loss of short-term memory.

Larry Steve Davidson, MD
(704) 792-2672
200 Medical Park Dr Ste 350
Concord, NC
Specialties
Neurological Surgery
Gender
Male
Education
Medical School: East Carolina Univ Sch Of Med, Greenville Nc 27858
Graduation Year: 1988

Data Provided by:
Russ A Bodner
(704) 262-1911
315 Medical Park Dr
Concord, NC
Specialty
Neurology

Data Provided by:
Francois Jacques Picot, MD
319 Penny Ln
Concord, NC
Specialties
Neurology
Gender
Male
Education
Medical School: Tulane Univ Sch Of Med, New Orleans La 70112
Graduation Year: 1989

Data Provided by:
Robert David Mitchell, MD
(704) 262-1911
319 Penny Ln
Concord, NC
Specialties
Neurology
Gender
Male
Education
Medical School: Univ Of Mi Med Sch, Ann Arbor Mi 48109
Graduation Year: 1982

Data Provided by:
Robert D Mitchell
(704) 262-1911
315 Medical Park Dr
Concord, NC
Specialty
Neurology

Data Provided by:
Mark Peter Redding, MD
(704) 792-2672
200 Medical Park Dr Ste 350
Concord, NC
Specialties
Neurological Surgery
Gender
Male
Education
Medical School: Univ Of Cincinnati Coll Of Med, Cincinnati Oh 45267
Graduation Year: 1990
Hospital
Hospital: Northeast Med Ctr, Concord, Nc; Carolinas Med Ctr, Charlotte, Nc
Group Practice: Carolina Neurosurgery & Spine

Data Provided by:
Christopher Connelly
(704) 262-1911
315 Medical Park Dr
Concord, NC
Specialty
Neurology

Data Provided by:
Daniel T Garber
(704) 403-1911
315 Medical Park Dr
Concord, NC
Specialty
Neurology

Data Provided by:
Christopher S Connelly, MD
(704) 262-1911
319 Penny Ln
Concord, NC
Specialties
Neurology
Gender
Male
Education
Medical School: Bowman Gray Sch Of Med Of Wake Forest Univ, Winston-Salem Nc 27157
Graduation Year: 1993
Hospital
Hospital: Northeast Med Ctr, Concord, Nc
Group Practice: Northeast Neurology

Data Provided by:
Connie Ching-yi Tsang
(704) 262-1911
315 Medical Park Dr
Concord, NC
Specialty
Neurology

Data Provided by:
Data Provided by:

Cancer Drug for Alzheimer's Treatment

Provided By:

TUESDAY, Sept. 8 (HealthDay News) -- New research suggests that a cancer drug might be able to restore day-to-day memory in patients with Alzheimer's disease.

The disease, the most common form of dementia among the elderly, is expected to afflict 120 million people worldwide by 2050. Often the first sign is loss of short-term memory.

"People often joke that they must have Alzheimer's because they can't remember where they put their keys, but for a person with the disease, this type of short-term memory loss is extremely debilitating," study author Ottavio Arancio, an associate professor of pathology and cell biology at Columbia University Medical Center, said in a news release.

The researchers examined a cancer drug from a family of compounds called HDAC inhibitors. The drug tinkers with DNA, and in the mice the researchers studied it appeared to make it easier for neurons in the brain to manufacture new proteins.

That process is critical in the process of recording new memories.

"Because this type of drug has already been approved for some cancer patients, we hope that clinical trials for Alzheimer's disease can start in about three to four years," said co-author Mauro Fa, an associate research scientist at Columbia.

The findings appear in the September issue of the Journal of Alzheimer's Disease.

More information

Learn more about memory from McGill University.

SOURCE: Columbia University, news release, Sept. 3, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com